Gagillapur: PFI Facility, Finished Dosage Facility, Research & Development Facility.

PFI Facility

• Capacity of 7200 MTPA.
  
  
• Operates on a modular concept with two modules.
  
  

Key features of Modules

Fluid Bed Granulation

• Large batch size of 6 MT
  
  
• 7200 MTPA capacity
  
  

High Shear Granulation

• Large batch size of 6 MT
  
  
• 7200 MTPA capacity
  
  

Multiple Finished Dosage Facility

• Plant design according to global standards
  
  
• Automated processes, with world-class facilities
  
  
• Installed capacity of 6 Billion Tablets/Caplets (Scalable to 12 Billion)
  
  
• Packing - Bulk, Bottle and Blister
  
  
• Dosage Forms – Tablets, Caplets, Capsules, Press-Fits, Effervescent Tablets and Sachet Powders (proposed)
  
  
• Coating – 3.2 billion
  
  

R&D/Pilot Facility

• Finished Dosage development
  
  
• PFI Development
  
  
• Geometrical Scale-up
  
  
• High shear as well as fluid bed granulation
  
  
• Class 100,000, spread over 5,200 sq. ft.
  
  
• R&D team of 60 members with independent FR&D, AR&D, RA and Sourcing activities
  
  
• Facilities meet global standards
  
  
• Ability to manufacture clinical/exhibit batches
  
  
• Pilot Facility approved by Canadian TPD and Australian TGA for small volume production
  
  

R&D/Pilot Formulation Equipment

• Blenders – 10 L and 200 L
  
  
• Blister Packing Machine
  
  
• Coating Machine – 12” / 18” and 36”
  
  
• Fluid Bed Processors – 5 L and 125 L
  
  
• High Shear Granulator – 10 L
  
  
• Tablet Press – 12 station (B, D & BB tooling) and Sejong 30 station
  
  
• Sifter, Mill, Balances, Test Apparatus, etc.
  
  

R&D Capabilities

• Highly experienced team
  
  
• Ability to develop several products and file ANDAs/Dossiers in the U.S., Canada, Europe, Australia & Other Countries
  
  
• Supported by scale-up and production facilities